AAAAAA

   
Results: 1-12 |
Results: 12
Three-dimensional quantitative structure-permeability relationship analysis for a series of inhibitors of rhinovirus replication
Authors: Ekins, S Durst, GL Stratford, RE Thorner, DA Lewis, R Loncharich, RJ Wikel, JH
Citation: S. Ekins et al., Three-dimensional quantitative structure-permeability relationship analysis for a series of inhibitors of rhinovirus replication, J CHEM INF, 41(6), 2001, pp. 1578-1586
Progress in predicting human ADME parameters in silico
Authors: Ekins, S Waller, CL Swaan, PW Cruciani, G Wrighton, SA Wikel, JH
Citation: S. Ekins et al., Progress in predicting human ADME parameters in silico, J PHARM TOX, 44(1), 2000, pp. 251-272
Application of MS-WHIM descriptors: 1. Introduction of new molecular surface properties and 2. Prediction of binding affinity data
Authors: Bravi, G Wikel, JH
Citation: G. Bravi et Jh. Wikel, Application of MS-WHIM descriptors: 1. Introduction of new molecular surface properties and 2. Prediction of binding affinity data, QSAR, 19(1), 2000, pp. 29-38
Application of MS-WHIM descriptors: 3. Prediction of molecular properties
Authors: Bravi, G Wikel, JH
Citation: G. Bravi et Jh. Wikel, Application of MS-WHIM descriptors: 3. Prediction of molecular properties, QSAR, 19(1), 2000, pp. 39-49
Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors
Authors: Ekins, S Bravi, G Binkley, S Gillespie, JS Ring, BJ Wikel, JH Wrighton, SA
Citation: S. Ekins et al., Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors, DRUG META D, 28(8), 2000, pp. 994-1002
Predicting drug-drug interactions in silico using pharmacophores: A paradigm for the next millennium
Authors: Ekins, S Ring, BJ Bravi, G Wikel, JH Wrighton, SA
Citation: S. Ekins et al., Predicting drug-drug interactions in silico using pharmacophores: A paradigm for the next millennium, IUL BIOTECH, 2, 2000, pp. 269-299
Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 3. Enhancing activity by imposing conformational restriction in the C-4" side chain
Authors: Bastian, JA Chirgadze, N Denney, ML Gifford-Moore, DS Sall, DJ Smith, GF Wikel, JH
Citation: Ja. Bastian et al., Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 3. Enhancing activity by imposing conformational restriction in the C-4" side chain, BIOORG MED, 9(3), 1999, pp. 363-368
Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors
Authors: Ekins, S Bravi, G Binkley, S Gillespie, JS Ring, BJ Wikel, JH Wrighton, SA
Citation: S. Ekins et al., Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors, PHARMACOGEN, 9(4), 1999, pp. 477-489
Three-dimensional-quantitative structure activity relationship analysis ofcytochrome P-450 3A4 substrates
Authors: Ekins, S Bravi, G Wikel, JH Wrighton, SA
Citation: S. Ekins et al., Three-dimensional-quantitative structure activity relationship analysis ofcytochrome P-450 3A4 substrates, J PHARM EXP, 291(1), 1999, pp. 424-433
Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors
Authors: Ekins, S Bravi, G Binkley, S Gillespie, JS Ring, BJ Wikel, JH Wrighton, SA
Citation: S. Ekins et al., Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors, J PHARM EXP, 290(1), 1999, pp. 429-438
Three-dimensional quantitative structure activity relationship analyses ofsubstrates for CYP2B6
Authors: Ekins, S Bravi, G Ring, BJ Gillespie, TA Gillespie, JS Vandenbranden, M Wrighton, SA Wikel, JH
Citation: S. Ekins et al., Three-dimensional quantitative structure activity relationship analyses ofsubstrates for CYP2B6, J PHARM EXP, 288(1), 1999, pp. 21-29
Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition. 3. Synthesis and biological activities of oxazolecarboxamide-substituted omega-phenyl-omega-(3-pyridyl)alkenoic acid derivatives and related compounds
Authors: Takeuchi, K Kohn, TJ True, TA Mais, DE Wikel, JH Utterback, BG Wyss, VL Jakubowski, JA
Citation: K. Takeuchi et al., Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition. 3. Synthesis and biological activities of oxazolecarboxamide-substituted omega-phenyl-omega-(3-pyridyl)alkenoic acid derivatives and related compounds, J MED CHEM, 41(27), 1998, pp. 5362-5374
Risultati: 1-12 |